Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

eUpdate – Thyroid Cancer Treatment Recommendations

ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer

Ann Oncol. 2022
S. Filetti, C. Durante, D. M. Hartl, S. Leboulleux, L.D. Locati, K. Newbold, M.G. Papotti & A. Berruti, on behalf of the ESMO Guidelines Committee

This update refers to the Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. S. Filetti, C. Durante, D. Hartl et al. Ann Oncol 2019; 30(12): 1856-1883.

  • This special article provides updated treatment recommendations on thyroid cancer.
  • New targeted systemic therapies have now been approved for treating patients with advanced/metastatic thyroid cancers.
  • This article summarises these new options and the order in which they should be used.
  • Recommendations are based on available scientific data and the authors' collective expert opinion.
  • Authorship includes a multidisciplinary group of thyroid cancer experts.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.